Employment Agreement, effective as of April 12, 2021, between the Company and Steven Pfanstiel
EMPLOYMENT AGREEMENT is effective on April 12, 2021 between Marinus Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Steven Pfanstiel, MBA, CMA (the “Employee”).
The parties desire to enter into this Agreement so as to provide for the employment of the Employee by the Company and for certain other matters in connection with such employment, all as set forth more fully in this Agreement.
NOW, THEREFORE, in consideration of the premises and covenants set forth herein, and intending to be legally bound hereby, the parties to this Agreement hereby agree as follows:
Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of the Employee’s execution of the Release, directly or indirectly, result in the Employee designating the calendar year of payment, and if a payment that is subject to execution of the Release could be made in more than one taxable year, payment shall be made in the later taxable year.
If to the Company:
Marinus Pharmaceuticals, Inc.
100 Matsonford Road
5 Radnor Corporate Center; Suite 500
Attention: Chief Executive Officer
If to the Employee, to address stated on the signature page to this Agreement.
Any party may from time to time change its address for the purpose of notices to that party by a similar notice specifying a new address, but no such change shall be deemed to have been given until it is actually received by the party sought to be charged with its contents.
(Signature page follows.)
IN WITNESS WHEREOF, this Agreement has been executed by the parties.
MARINUS PHARMACEUTICALS, INC.
By: /s/ Scott Braunstein, MD
Scott Braunstein, MD
Chief Executive Officer
Date: March 7, 2021
/s/ Steven Pfanstiel
By: Steven Pfanstiel, MBA, CMA
Date: March 5, 2021